Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-26 Purchase |
2022-05-31 5:17 pm |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
43,900 | $0.18188 | $7,985 | 585,248 (Indirect Direct) |
View |
| 2022-03-03 Purchase |
2022-03-09 4:01 pm |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
139,488 | $0.391 | $54,540 | 249,674 (Direct) |
View |
| 2021-08-17 Purchase |
2021-08-17 4:08 pm |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
4,000 | $0.8955 | $3,582 | 102,247 (Indirect) |
View |
| 2020-08-19 Purchase |
2020-08-20 07:59 am |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
2,000 | $1.01 | $2,020 | 2,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-04-11 Option Award |
2024-04-12 4:50 pm |
2025-04-11 2034-04-11 |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 4:04 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
14,300 | $0 | 49,135 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 5:33 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
20,000 | $0 | 34,835 (Direct) |
View |
| 2022-11-03 Option Award(A) |
2022-12-12 6:34 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
2,693 | $1.734 | 14,835 (Direct) |
View |
| 2022-11-03 Option Award(A) |
2022-11-08 5:42 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
10,000 | $1.734 | 22,142 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-07 4:34 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
10,000 | $1.734 | 313,574 (Direct) |
View |
| 2022-05-03 Option Award |
2022-05-05 4:06 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
10,000 | $0.1863 | 259,674 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-21 4:08 pm |
N/A 2032-01-19 |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2021-11-03 Option Award |
2021-11-05 2:58 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
7,939 | $0.718 | 110,186 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-05 5:10 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
9,822 | $0.567 | 96,247 (Direct) |
View |
| 2020-12-02 Option Award |
2020-12-04 5:05 pm |
N/A 2030-12-01 |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2020-11-03 Option Award |
2020-11-05 5:44 pm |
N/A N/A |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
4,879 | $0.561 | 86,425 (Direct) |
View |
| 2020-07-14 Option Award |
2020-07-16 8:56 pm |
N/A 2030-07-13 |
Salarius Pharmaceuticals Inc. | SLRX | Arthur David J. Chief Executive Officer |
339,584 | $0 | 339,584 (Direct) |
View |